Well Referenced

Tag: Tibolone

Sexual dysfunction in the peri- and postmenopause. Status of incidence, pharmacological treatment and possible risks. A secondary publication

This observational study examined sexual dysfunction (SD) in peri- and postmenopausal women, assessing its incidence, pharmacological treatment options, and associated risks. Findings indicate that SD increases with age and worsens during menopause, with systemic hormone therapies (estrogen, estrogen/progesterone, estrogen/testosterone, and tibolone) improving symptoms. Local estrogen treatments effectively relieve vaginal dryness

Read More »
June 26, 2025 No Comments

Sexuality and the menopause

This article examines the impact of menopause on women’s sexuality, highlighting challenges in assessing hormone levels due to ethnic variability and measurement limitations. It discusses differences in prevalence rates of female sexual dysfunction between cross-sectional and longitudinal studies and critiques traditional models of sexual response. The study also notes the

Read More »
June 26, 2025 No Comments